Nagano Chuo Hospital Balloon Ablation Study

Nagano Chuo Hospital Balloon Ablation Study - Hot and Ice Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035284

Enrollment

200

Registered

2018-12-27

Start date

2019-01-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

HotBalloon ablation Sheath:TRESWALTZ Balloon:SATAKE HotBalloonCatheter(Injection volume:8~20ml) CryoBalloon ablation Sheath:FlexCath Advance Steerable Sheath Balloon:Arctic Front Advance Cryo Ba

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with paroxysmal atrial fibrillation qualified to catheter ablation according to current standards

Exclusion criteria

Exclusion criteria: 1. unsuitable anatomy of pulmonary vein or left atrium for balloon ablation 2. life expectancy < 12 months 3. difficult to follow up 12 months

Design outcomes

Primary

Measure	Time frame
Recurrence of any atrial fibrillation or atrial tachycardia by 12 months from ablation	—

Secondary

Measure	Time frame
1.touch-up rate by radio-frequency ablation 2.procedure time (From puncture start to sheath removal) 3.fluoroscopy time 4.complications rate by treatment (Period: 3 months)	—

Countries

Japan

Contacts

Public ContactDaisuke Yamagishi

Nagano Chuo Hospital Department of Heart Disease Center

hdc@healthcoop-nagano.or.jp026-234-3211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026